CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,137,000 | -13.9% | 25,000 | 0.0% | 0.03% | +7.7% |
| Q1 2018 | $1,320,000 | -22.4% | 25,000 | 0.0% | 0.03% | -16.1% |
| Q4 2017 | $1,700,000 | -31.2% | 25,000 | -16.7% | 0.03% | -35.4% |
| Q3 2017 | $2,472,000 | +164.1% | 30,000 | +200.0% | 0.05% | +65.5% |
| Q2 2017 | $936,000 | -63.3% | 10,000 | -75.0% | 0.03% | -58.0% |
| Q1 2017 | $2,547,000 | -25.6% | 40,000 | -57.9% | 0.07% | -41.5% |
| Q3 2016 | $3,425,000 | – | 95,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |